TCG Crossover Management, LLC
Top Portfolio Positions
49 positions ·
$3,501,388,578 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ABVX |
Abivax S.A.
Healthcare
|
6,481,085 | $721,668,814 | 20.61% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
3,670,206 | $248,399,542 | 7.09% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
10,531,071 | $220,310,005 | 6.29% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
4,946,894 | $190,405,950 | 5.44% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
4,286,480 | $170,258,985 | 4.86% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
1,676,624 | $140,702,286 | 4.02% | |
| TYRA |
Tyra Biosciences, Inc.
Healthcare
|
3,248,980 | $124,435,934 | 3.55% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
4,457,988 | $110,736,421 | 3.16% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
11,020,968 | $104,919,615 | 3.00% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
5,673,078 | $101,207,711 | 2.89% |
Portfolio Trend
18 quarters · across all stocks
Holdings in COGT
Shares Held
Position Value (USD)
18 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $190,405,950 | 4,946,894 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $208,437,114 | 5,868,162 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $97,621,606 | 6,798,162 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $50,004,212 | 6,964,375 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $41,716,606 | 6,964,375 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $54,322,125 | 6,964,375 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $75,215,250 | 6,964,375 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $58,709,681 | 6,964,375 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $41,760,600 | 6,214,375 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $33,110,526 | 5,631,042 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $54,902,659 | 5,631,042 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $66,671,537 | 5,631,042 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $39,178,943 | 3,631,042 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $41,974,845 | 3,631,042 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $51,937,146 | 3,481,042 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $31,398,998 | 3,481,042 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,328,004 | 2,981,042 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $23,595,317 | 2,750,037 | Shares | Sole | 2022-02-18 | |
| No 13F history on record for this holder in this stock. | ||||||